Wilbanks Smith & Thomas Asset Management LLC Ptc Therapeutics, Inc. Transaction History

Wilbanks Smith & Thomas Asset Management LLC

$3.54 Billion
Q1 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2018 Feb 08, 2019	SELL	$29.83 - $46.51 $5,220 - $8,139	-175 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$33.9 - $47.77 $5,932 - $8,359	175 New	175 $8,000

Others Institutions Holding PTCT

# of Institutions

215

Shares Held

79.2M

Call Options Held

122K

Put Options Held

212K

Vanguard Group Inc Valley Forge, PA

8.97M
Shares

$305 Million
0.01% of portfolio
Wellington Management Group LLP Boston, MA

8.21M
Shares

$279 Million
0.05% of portfolio
Black Rock Inc. New York, NY

7.77M
Shares

$264 Million
0.01% of portfolio
Rtw Investments, LP New York, NY

7.39M
Shares

$251 Million
3.78% of portfolio
Armistice Capital, LLC New York, NY

6.96M
Shares

$237 Million
2.77% of portfolio

View Full List

About PTC THERAPEUTICS, INC.

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $2.43B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

More about PTCT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wilbanks Smith & Thomas Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wilbanks Smith & Thomas Asset Management LLC with notifications on news.

Account